[Form 3] LifeMD, Inc. Initial Statement of Beneficial Ownership

Rhea-AI Filing Summary

LifeMD, Inc. executive Christopher A. Pisano, the company’s Chief Marketing Officer, filed an initial Form 3 as a reporting person. The filing lists no transactions or holdings, serving as a baseline disclosure of his status as an officer subject to insider reporting rules.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Pisano Christopher A

(Last) (First) (Middle)

C/O LIFEMD

236 FIFTH AVENUE, SUITE 400

(Street)

NEW YORK NEW YORK 10001

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/16/2026

3. Issuer Name and Ticker or Trading Symbol
LifeMD, Inc. [ LFMD ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Marketing Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Christopher A. Pisano	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the LifeMD (LFMD) Form 3 filing by Christopher A. Pisano show?

The Form 3 filing shows that Christopher A. Pisano is a reporting person for LifeMD as its Chief Marketing Officer. It is an initial ownership statement and, in this case, reports no transactions or derivative positions in LifeMD securities.

Who is the insider named in the LifeMD (LFMD) Form 3?

The insider named is Christopher A. Pisano, identified as an officer of LifeMD with the title Chief Marketing Officer. This establishes him as a person required to provide ongoing ownership and transaction reports under insider reporting rules.

Does the LifeMD (LFMD) Form 3 for Christopher A. Pisano report any stock transactions?

No, the Form 3 for Christopher A. Pisano reports no stock transactions. The transaction summary shows zero buys, sells, exercises, gifts, tax withholdings, or restructurings, indicating this filing is purely an initial status disclosure.

Are any derivative securities reported in the LifeMD (LFMD) Form 3 for Christopher A. Pisano?

No derivative securities are reported for Christopher A. Pisano in this Form 3. The derivativeSummary is empty and the derivative transaction count is zero, meaning no options, warrants, or other derivatives are listed in this initial filing.

What do the transactionSummary counts in the LifeMD (LFMD) Form 3 indicate?

The transactionSummary shows all categories, including buyCount, sellCount, and exerciseCount, at zero. This indicates there were no reportable purchases, sales, exercises, gifts, or restructurings associated with Christopher A. Pisano in this initial statement.